SPRINGFIELD, IL — Members of both chambers of the Illinois legislature have advanced legislation, Senate Bill 2023, to expand the state’s medical cannabis access program.
The measure expands the pool of patients who are eligible to participate in the state’s medical program to include those diagnosed with autism, chronic pain, and Ehlers-Danlos syndrome (among other debilitating conditions), facilitates relationships between financial institutions and licensed medical cannabis businesses, and permits students to access infused cannabis products on school grounds, among other changes.
The measure now awaits action from Democratic Gov. J.B. Pritzker.
Separate legislation before the governor, The Cannabis Regulation and Tax Act, would allow patients for the first time to cultivate personal use amounts of cannabis at home. The Governor is anticipated to sign both bills.
Once signed, SB 2023 takes immediate effect.
An estimated 40,000 Illinois residents are registered in the state’s medical cannabis access program.
Tags: autism, chronic pain, Ehlers-Danlos syndrome, IL SB 2023, Illinois medical marijuana
